JAZZ FY 2021 Earnings — Jazz Pharmaceuticals plc Revenue & Financial Results | Market Cap Arena

JAZZJazz Pharmaceuticals plc

$12B

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3.1B+30.9% YoY

Gross Profit

$2.7B85.8% margin

Operating Income

$170M5.5% margin

Net Income

-$329M-10.6% margin

EPS (Diluted)

$-5.51

Cash Flow

Operating Cash Flow

$779M

Free Cash Flow

$733M

Stock-Based Comp.

$189M

Balance Sheet

Total Assets

$12.3B

Total Liabilities

$8.3B

Stockholders' Equity

$4.0B

Cash & Equivalents

$591M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3.1B	$2.4B	+30.9%
Gross Profit	$2.7B	$2.2B	+19.8%
Operating Income	$170M	$378M	-55.0%
Net Income	-$329M	$239M	-237.9%